Aroa Biosurgery LtdAroa Biosurgery LtdAroa Biosurgery Ltd

Aroa Biosurgery Ltd

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪231.17 M‬AUD
−0.010AUD
‪−3.47 M‬AUD
‪77.10 M‬AUD
‪227.68 M‬
Beta (1Y)
0.94

About Aroa Biosurgery Ltd


CEO
Brian Roderick Ward
Website
Headquarters
Mangere
Founded
2008
ISIN
NZARXE0001S1
FIGI
BBG00VX929P6
Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. It focuses on healing for complex wounds, and soft tissue reconstruction procedures including abdominal wall reconstruction, breast reconstruction, and reconstructive surgery for trauma, limb salvage, and tumor resections. The company was founded by Brian Roderick Ward in 2008 and is headquartered in Mangere, New Zealand.

Check out other big names from the same industry as ARX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ARX is 0.665 AUD — it has decreased by −0.75% in the past 24 hours. Watch Aroa Biosurgery Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Aroa Biosurgery Ltd stocks are traded under the ticker ARX.
ARX stock has fallen by −5.00% compared to the previous week, the month change is a 3.10% rise, over the last year Aroa Biosurgery Ltd has showed a 34.34% increase.
We've gathered analysts' opinions on Aroa Biosurgery Ltd future price: according to them, ARX price has a max estimate of 0.89 AUD and a min estimate of 0.76 AUD. Watch ARX chart and read a more detailed Aroa Biosurgery Ltd stock forecast: see what analysts think of Aroa Biosurgery Ltd and suggest that you do with its stocks.
ARX reached its all-time high on Jul 30, 2020 with the price of 1.745 AUD, and its all-time low was 0.350 AUD and was reached on Apr 7, 2025. View more price dynamics on ARX chart.
See other stocks reaching their highest and lowest prices.
ARX stock is 3.08% volatile and has beta coefficient of 0.94. Track Aroa Biosurgery Ltd stock price on the chart and check out the list of the most volatile stocks — is Aroa Biosurgery Ltd there?
Today Aroa Biosurgery Ltd has the market capitalization of ‪231.17 M‬, it has decreased by −4.29% over the last week.
Yes, you can track Aroa Biosurgery Ltd financials in yearly and quarterly reports right on TradingView.
Aroa Biosurgery Ltd is going to release the next earnings report on Nov 25, 2025. Keep track of upcoming events with our Earnings Calendar.
ARX earnings for the last half-year are 0.01 AUD per share, whereas the estimation was 0.00 AUD, resulting in a 175.00% surprise. The estimated earnings for the next half-year are −0.01 AUD per share. See more details about Aroa Biosurgery Ltd earnings.
Aroa Biosurgery Ltd revenue for the last half-year amounts to ‪41.42 M‬ AUD, despite the estimated figure of ‪38.89 M‬ AUD. In the next half-year revenue is expected to reach ‪41.96 M‬ AUD.
ARX net income for the last half-year is ‪−470.00 K‬ AUD, while the previous report showed ‪−3.01 M‬ AUD of net income which accounts for 84.41% change. Track more Aroa Biosurgery Ltd financial stats to get the full picture.
No, ARX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aroa Biosurgery Ltd EBITDA is ‪823.77 K‬ AUD, and current EBITDA margin is 1.11%. See more stats in Aroa Biosurgery Ltd financial statements.
Like other stocks, ARX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aroa Biosurgery Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aroa Biosurgery Ltd technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aroa Biosurgery Ltd stock shows the neutral signal. See more of Aroa Biosurgery Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.